Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Rising at 15.80% CAGR, Cell Culture Media Market Share to Reach USD 11,372.175 Million, Globally by 2028: Comprehensive Research Report by Facts & Factors

Published

on

NEW YORK, United States, Aug. 09, 2022 (GLOBE NEWSWIRE) — According to Facts and Factors has published a new research report titled “Cell Culture Media Market Size, Share, Growth Analysis Report By Type (Serum-free Media, CHO Media, HEK 293 Media, BHK Media, VERO Cell Media, Insect Cell Medi, Serum-free Stem Cell Media, CAR T-cell Media, Other Serum-free Media, Classical Media & Salts, Stem Cell Culture Media, Specialty Media, Chemically defined Media, Other Cell Culture Media), By Application (Biopharmaceutical Production, Monoclonal antibodies, Vaccines production, Other therapeutic proteins, Diagnostics, Drug Screening & Development, Tissue Engineering & Regenerative Medicine, Cell and gene therapy, Other tissue engineering & regenerative medicine applications, Other Applications), By End-user (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Other End Users), and By Region – Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” in its research database.

“According to the latest research study, the demand of global Cell Culture Media Market size & share in terms of revenue was valued at USD 4,716.20 million in 2021 and it is expected to surpass around USD 11,372.175 million mark by 2028, growing at a compound annual growth rate (CAGR) of approximately 15.80% during the forecast period 2022 to 2028.”

Report Overview:

Cell culture media is the nutritional growth medium needed for cell cultures to develop and endure under particular incubation circumstances. It is made to facilitate the development of cells or microbes. Ingredients in the Cell Culture medium serve as a source of energy and control the cell cycle of in-vitro developing cells. Vitamins, amino acids, glucose, growth hormones, and inorganic salts are all components of a primary cell culture medium. The medium also aids in preserving the osmolarity and pH of the grown cells.

Click Here To AccessFree Sample Report of the Global Cell Culture Media Market @ https://www.fnfresearch.com/sample/cell-culture-media-market

(A free sample of this report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the Following:

  • Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
  • The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
  • About 205+ Pages Research Report (Including Recent Research)
  • Provide detailed chapter-by-chapter guidance on Request
  • Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
  • Includes Tables and figures have been updated
  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
  • Facts and Factors research methodology

(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)

Global Cell Culture Media Market Dynamics

A culture medium is a solid, liquid, or semi-solid created to promote the proliferation of cells to enable the growth of a population of microorganisms or cells. Different cell types are grown in various kinds of mediums. Monoclonal antibody development may benefit from cell culture technologies. These antibodies may be made synthetically in labs using a cell culture medium. The cell culture medium is used in the biological sciences to encourage the development of cells and microorganisms. The term “cell culture medium” refers to a growth agent necessary for cell cultures to develop and endure under particular circumstances. Numerous substances, including amino acids, glucose, serum, and inorganic salts, encourage cell development. The cell culture medium also maintains the pH balance of the cultivated cells.

The culture media includes several nutrients that support the development, expansion, maintenance, and preservation of microorganisms and other cell types, such as stem cells or other cell lines. Different culture media are offered on the market and can survive and prosper in their incubation conditions. This market’s expansion is primarily fueled by rising pharmaceutical companies, new cell culture technologies for cell-based vaccines, rising monoclonal antibody demand, development of stem cell research, the introduction of new cell culture media by industry participants, and a growing emphasis on personalized medicine. On the other hand, high costs and ethical issues with cell biology research are anticipated to restrain the development of this industry. The need for cell culture medium approaches has increased in response to the rising demand for manufacturing vaccines and monoclonal antibodies.

However, the rate of expansion of the cell culture medium market would be severely hampered by strict rules and regulations for process manufacturing. The lack of informed experts or qualified professionals will also cause the rate of industry expansion to slow down. Additionally, the high price of cell biology research will slow the rate of market expansion.

Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/cell-culture-media-market

Cell Culture Media Market: COVID-19 Impact Analysis

As a result of the COVID-19 epidemic, the world’s healthcare systems are under significant strain. Because of the shutdown that affected the region as a whole, businesses during that time encountered difficulties with their workforce. Vaccines made from human cells are going to be used to protect humans. Researchers have created culture-based immunizations in response to the rising demand for vaccines and the stringent safety rules for novel vaccines that are meant to minimize and halt the spread of infectious diseases. The government planned to take advantage of technologies involving cell culture in order to speed up the production of vaccines. Since COVID-19 speeds up the process of making vaccines, it is good for the culture and media market.

Segmentation Analysis

The global cell culture media market is segregated based on type, application, end-user, and region. On the basis of type, the market is classified into serum-free media, CHO media, HEK 293 media, BHK media, VERO cell media, insect cell media, serum-free stem cell media, CAR T-cell media, other serum-free media, classical media & salts, stem cell culture media, specialty media, chemically defined media, other cell culture media. Among these, the serum-free stem cell media segment led the market in 2021 and is expected to maintain its dominance throughout the forecast period.

Based on application, the market is classified into biopharmaceutical production, monoclonal antibodies, vaccine production, other therapeutic proteins, diagnostics, drug screening & development, tissue engineering & regenerative medicine, cell and gene therapy, and other tissue engineering & regenerative medicine applications, other applications. In 2021, the cell culture media industry will be dominated by biopharmaceutical production. Based on end users, the market is classified into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and other end users. In 2021, the market was dominated by pharmaceutical & biotechnology companies 2021.

The global Cell Culture Media market is segmented as follows:

By Type

  • Serum-free Media
  • CHO Media
  • HEK 293 Media
  • BHK Media
  • VERO Cell Media
  • Insect Cell Media
  • Serum-free Stem Cell Media
  • CAR T-cell Media
  • Other Serum-free Media
  • Classical Media & Salts
  • Stem Cell Culture Media
  • Specialty Media
  • Chemically defined Media
  • Other Cell Culture Media

By Application

  • Biopharmaceutical Production
  • Monoclonal antibodies
  • Vaccine’s production
  • Other therapeutic proteins
  • Diagnostics
  • Drug Screening & Development
  • Tissue Engineering & Regenerative Medicine
  • Cell and gene therapy
  • Other tissue engineering & regenerative medicine applications
  • Other Applications

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Other End Users

Browse the full “Cell Culture Media Market – Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028” Report at https://www.fnfresearch.com/cell-culture-media-market

Competitive Landscape

Some of the main competitors dominating the global Cell Culture Media market include – 

  • InstaReMPvt. Ltd.
  • Ria Financial Services Ltd.
  • Western Union Holdings Inc.
  • PayPal Holdings Inc.
  • WorldRemit Ltd.
  • Digital Wallet Corporation
  • TransferWise Ltd.
  • Azimo Limited
  • TransferGo Ltd.
  • MoneyGram.

Key Insights from Primary Research:

  • According to the analysis shared by our research forecaster, the Cell Culture Media market is likely to expand at a CAGR of around 15.80% during the forecast period (2022-2028).
  • In terms of revenue, the Cell Culture Media market size was valued at around US$ 4,716.20 million in 2021and is projected to reach US$ 11,372.175 million by 2028.
  • Based on type segment, the serum-free stem cell medium segment is predicted to lead the market in 2021.
  • Biopharmaceutical production will be the dominant force in the cell culture media market by 2021, based on application segment.
  • North America dominated the global cell culture media market in 2021.

Have Any Query? Ask Our Experts: https://www.fnfresearch.com/inquiry/cell-culture-media-market

Key questions answered in this report:

  • What is the market size and growth rate forecast for Cell Culture Media industry?
  • What are the main driving factors propelling the Cell Culture Media Market forward?
  • What are the leading companies in the Cell Culture Media Industry?
  • What segments does the Cell Culture Media Market cover?
  • How can I receive a free copy of the Cell Culture Media Market sample report and company profiles?

Key Offerings:

  • Market Size & Forecast by Revenue | 2022−2028
  • Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities
  • Market Segmentation – A detailed analysis By Type, Application, End-User, and Region
  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Request for Customization on this Report as per your requirements – https://www.fnfresearch.com/customization/cell-culture-media-market

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Regional Analysis:

The global cell culture media market is divided into geographic regions: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America dominates the global market for cell culture media. In North America, there has been a considerable increase in the demand for cell biology research and cell culture technology. Businesses have begun to invest in novel approaches and advancements in cell culture applications. North America, which held the most significant share of this market, was the area with the most active research and development initiatives about cytological examination for proteomics, genomics, and medicine and vaccine development. During the projection period, it is also predicted that rising demand for biopharmaceuticals would propel regional market expansion.

By Region

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • France
    • UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of Asia Pacific
  • The Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Recent Developments

  • July 2021: The Gibco Cell Therapy Systems (CTS) NK-Xpander Medium, which facilitates the large-scale development and culture of functional natural killer (NK) cells with or without the assistance of feeder cells, was introduced by Thermo Fisher Scientific Inc. (US).
  • October 2021: By acquiring cell culture expert Xell AG, Sartorius AG increased its capacity for producing dry powder and liquid media.

Report Scope

Report Attribute Details
Market Size in 2021 USD 4,716.20 Million
Projected Market Size in 2028 USD 11,372.175 Million
CAGR Growth Rate 15.80% CAGR
Base Year 2021
Forecast Years 2022-2028
Key Market Players InstaReM Pvt. Ltd., Ria Financial Services Ltd., Western Union Holdings Inc., PayPal Holdings Inc., WorldRemit Ltd., Digital Wallet Corporation, TransferWise Ltd., Azimo Limited, TransferGo Ltd., MoneyGram, and Others
Key Segment By Type, Application, End-User, and Region
Major Regions Covered North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Purchase Options Request customized purchase options to meet your research needs.

To know an additional revised 2022 list of market players, request a sample report @ https://www.fnfresearch.com/sample/cell-culture-media-market

Browse Other Related Research Reports from Facts & Factors:

Global Sterile Swabs Market Projected to Reach USD 4 Billion By 2026: https://www.fnfresearch.com/sterile-swabs-market

Global Artificial Tendons and Ligaments Market Projected to Reach USD 40 Million By 2026: https://www.fnfresearch.com/artificial-tendons-and-ligaments-market-by-application-shoulder

Global Varicose Vein Treatment Market Projected to Reach USD 1796.4 Million by 2026: https://www.fnfresearch.com/varicose-vein-treatment-market-by-product-ablation-devices-700

Global Cancer Supportive Care Drug Market Projected Around USD 22,760.32 Million by 2026: https://www.fnfresearch.com/cancer-supportive-care-drug-market-by-product-type-937

Global Bio Chips Market Projected to Reach USD 56.5 Billion by 2026: https://www.fnfresearch.com/bio-chips-market-by-product-dna-chip-protein-896

Global Tissue Patch Market Projected to Reach USD 12,000.00 Million by 2026: https://www.fnfresearch.com/tissue-patch-market-by-application-hernia-repair-dural-819

About Facts & Factors:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us on LinkedIn: https://www.linkedin.com/company/fnfresearch

Follow Us on Twitter: https://twitter.com/fnfresearch

Follow Us on Facebook: https://www.facebook.com/factsandfactors/

Contact Us:

Rushikesh Dorge

USA: +1 347 690-0211

United Kingdom: +44 2032 894158

Japan: +81 50 5806 9039

India: +91 73877 19999

Email: [email protected]

Web: https://www.fnfresearch.com

Blog: http://fnfnewsblog.com

Artificial Intelligence

Creditflux announces 2024 CLO Manager Awards winners

Published

on

creditflux-announces-2024-clo-manager-awards-winners

The Creditflux awards are the only credit fund and CLO industry awards solely determined by data and metrics, showcasing the market’s best performers. 
LONDON, May 16, 2024 /PRNewswire/ — Creditflux, a Debtwire service and part of ION Analytics, held its 16th annual CLO Manager Awards in London on 15 May 2024. The global collateralized loan obligation (CLO) community gathered at London’s Landmark Hotel to recognize the best-performing CLOs, CLO managers, and CLO funds in the USD 1.32tn* global CLO market.

This year, a record 80 CLO managers and 32 CLO fund managers submitted performance data for the awards. The list of finalists was announced in April and the category winners were announced live during the Creditflux Manager Awards Dinner, attended by 320 guests.
The awards ceremony followed a full-day Creditflux-hosted CLO Symposium that connected CLO investors with the most important arrangers, managers, and advisors in global structured finance, helping the former to deploy capital and achieve investment goals. The CLO Symposium also provided an outlook on the major trends in the US and European CLO markets, covering current topics in primary and secondary opportunities.
“Despite a backdrop of market volatility and macro-economic challenges, 2023 was another strong year for the CLO market,” said Tom Davidson, Managing Editor of Creditflux. “We are delighted to celebrate the best performers in the industry, presenting awards to the 16 managers who triumphed this year.” 
More details on the methodology for the awards can be found here. The winners are:
Category 
Winner 
CLO/Fund 
Managers 
Creditflux global manager of the year 
GoldenTree Asset Management
Best US CLO manager 
Generate Advisors 
Best European CLO manager 
Voya Alternative Asset Management 
Best US boutique CLO manager 
Sycamore Tree 
Best European boutique CLO manager 
Acer Tree Investment Management 
Best MM CLO manager 
Antares Capital 
Funds 
Best private closed-end CLO fund 
Napier Park Global Capital 
Napier Park ELM I 
Best public closed-end CLO fund 
Eagle Point Income Management 
Eagle Point Income Company (EIC) 
Best CLO fund ($150m) 
Crystal Fund 
BK Opportunities Fund V 
CLOs 
Best US CLO 
Elmwood Asset Management 
Elmwood CLO V 
Best European CLO 
Invesco 
Invesco Euro CLO IV 
Best redeemed US CLO 
CSAM 
Madison Park Funding XLI 
Best new middle market CLO 
Cerberus Business Finance 
Cerberus Loan Funding XL 
Best middle market CLO 
Golub Capital 
Golub Capital Partners CLO 47 (M) 
Best new US CLO 
MJX Asset Management 
Venture 47 CLO 
Best new European CLO 
Blackstone Credit 
Glenbrook Park CLO 
*
Global CLO principal liabilities (debt + equity) as of 31 March 2024 according to Creditflux data
About Creditflux
Creditflux, by Debtwire is the leading source for CLO and credit trading news, data, and analysis globally. Established in 2001, its team of journalists and analysts in New York and London produces daily content online and a monthly print magazine that is the publication of choice for many market professionals, including investors, dealers, brokers, analysts, and service providers. Creditflux is an ION Analytics service.
About ION Analytics
ION Analytics delivers personalized, targeted data, market intelligence, and software to banks, investors, and corporates, helping clients find opportunities and drive better decisions in markets ranging from equities and fixed income to infrastructure and private equity. For more information, visit https://ionanalytics.com   
About ION
ION provides mission-critical trading and workflow automation software, high-value analytics and insights, and strategic consulting to financial institutions, central banks, governments, and corporate organizations. Our solutions and services simplify complex processes, boost efficiency, and enable better decision-making. We build long-term partnerships with our clients, helping transform their businesses for sustained success through continuous innovation. For more information, visit https://iongroup.com/
All product and company names herein may be trademarks of their registered owners.

View original content:https://www.prnewswire.co.uk/news-releases/creditflux-announces-2024-clo-manager-awards-winners-302146755.html

Continue Reading

Artificial Intelligence

New Clarivate Report Reveals that the U.S., Germany and Mainland China have the most Non-Practicing Entity Litigation

Published

on

new-clarivate-report-reveals-that-the-us.,-germany-and-mainland-china-have-the-most-non-practicing-entity-litigation

Infringement declined globally from 2012 to 2019
LONDON, May 16, 2024 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released the 2024 Non-Practicing Entity Global Litigation (NPE) Report to analyze NPE enforcement activities and their patent validity challenges across the globe. The report revealed that the United States, Germany and Mainland China are the three countries and regions with the most infringement cases filed by NPEs.

For this report, NPE is defined as an independent legal organization which owns or benefits from patent rights but does not sell or manufacture goods or provide goods-related services. Using the Clarivate Darts-ipTM database of patent case law, this report showed that among the countries and regions where most of infringement cases are filed by NPEs between 2018-2023, the U.S. accounts for 97.2% of the total, while Germany and Mainland China count for 1.8% and 0.4% respectively. However, the growth momentum differs in the top three countries when comparing 2012-2017 to 2018-2023. There was a 43% decrease in the number of U.S. NPE infringement cases, while the number in Mainland China increased 600% and Germany saw a strong decline starting in 2018.
This report showed that during 2012-2017, there was an undeniable trend of increasing patent validity challenges overall and of patent validity challenges filed against NPEs worldwide. While overall patent validity challenges slightly increased during 2018-2023, the number of patent validity challenges filed against NPEs worldwide slightly decreased.
Francois Neuville, Senior Vice President, Brand IP, Clarivate, said, “NPEs should now be considered as part of the patent ecosystem. These entities seek out courts where they can further monetize the value of their IP assets, using litigation as both leverage and means. As NPE litigation continues to evolve worldwide, analyzing trends using enriched data and insights can help support informed decisions for the future.”
Other key findings in the report include:
Overall, infringement action filed by NPEs declined globally from 2012 to 2019. Starting in 2020, NPE infringement cases began to stabilize at around 2,000 per year.NPEs are well known for being active in Information and Communication Technologies (i.e. digital communication, telecommunications, computer technology and audio-visual technology). These technologies account for 64% of the patents asserted by NPEs in the U.S. and for 74% of the patents asserted by NPEs in EU.Patents belonging to NPEs are being invalidated at greater frequency than non-NPEs. This may indicate that the NPEs are facing patent quality challenges.Learn more about NPE litigation worldwide trends here.
MethodologyFor this report, we consider NPEs to be independent organizations (legal entities) which own or benefit from patent rights but do not sell or manufacture goods or services associated with them (i.e., non-operating companies) and which have an active (offensive) assertion or litigation role as plaintiffs towards the enforcement of their patent rights. Read our full methodology here.
About ClarivateClarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com
Media contactJack WanExternal Communications [email protected]
Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/new-clarivate-report-reveals-that-the-us-germany-and-mainland-china-have-the-most-non-practicing-entity-litigation-302146460.html

Continue Reading

Artificial Intelligence

Unitree Robotics issues G1 Humanoid agent AI avatar

Published

on

unitree-robotics-issues-g1-humanoid-agent-ai-avatar

HANGZHOU, China, May 16, 2024 /PRNewswire/ — On May 13, Unitree Robotics introduced its latest masterpiece — Unitree G1 Humanoid agent, AI avatar! It immediately caused a sensation in the global AI and robotics fields.

The robot is about 127 centimeters tall and weighs about 35 kilograms. It has flexibility beyond ordinary people and unlocks unlimited movement potential. The walking speed of G1 is about 2m/s. It has a large joint movement space, with 23-43 joints, and the maximum joint torque can reach 120N.m. It can perform high-load dynamic movements, such as dynamic stand-up, seat folding, dance stick, etc. At the same time, G1 is based on deep reinforcement learning and simulation training, and uses the accelerated development of AI to continuously upgrade and evolve.
G1 can be equipped with the optional Dex3-1 force-controlled dexterous hand. Through force-position hybrid control, G1 can simulate the precise operation ability of the human hand and accurately control various objects. Whether it is smashing walnuts, carrying heavy objects, or picking up fragile objects such as eggs, the G1 can demonstrate extremely high accuracy and stability. What’s more worth mentioning is that the G1 robot can also easily handle delicate operations such as opening soda bottles and welding. These tasks that were considered difficult for machines in the past have now become a piece of cake under the dexterous control of the G1.
The G1 is equipped with Intel RealSense D435 and LIVOX-MID360 3D lidar, which can achieve 360° detection and perception. These sensors provide a powerful perception hardware foundation, allowing G1 to better understand the surrounding environment. In addition, the G1 power supply module supports two hours of battery life and quick disassembly.
There are two versions of the G1 humanoid robot released this time, namely G1 and G1 EDU. The price of G1 is $16k. As an advanced version, G1 EDU provides a combination of different module solutions, and the price is customized according to different customer needs. Compared with G1, G1 EDU supports Dex3-1 force-controlled dexterous hand installation, optional tactile sensor arrays, greater knee joint torque and arm load, and optional NVIDIA Jetson Orin high computing power module to support secondary development.
Unitree also released the robot world model, providing a co-creation platform: UnifoLM (Unitree Robot Unified Large Model), allowing everyone to jointly create a new era of intelligent agents and explore unlimited innovation possibilities.
Introduction: https://www.unitree.com/g1 
Website: www.unitree.com 
Contact: [email protected] 
Photo – https://mma.prnewswire.com/media/2413301/Unitree_G1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/unitree-robotics-issues-g1-humanoid-agent-ai-avatar-302146425.html

Continue Reading

Trending